Pearson, Toni S. http://orcid.org/0000-0002-3679-7707
Gupta, Nalin http://orcid.org/0000-0001-9539-7052
San Sebastian, Waldy
Imamura-Ching, Jill
Viehoever, Amy http://orcid.org/0000-0002-8758-5632
Grijalvo-Perez, Ana
Fay, Alex J.
Seth, Neha
Lundy, Shannon M.
Seo, Youngho http://orcid.org/0000-0001-5908-6636
Pampaloni, Miguel
Hyland, Keith
Smith, Erin
de Oliveira Barbosa, Gardenia
Heathcock, Jill C.
Minnema, Amy
Lonser, Russell
Elder, J. Bradley
Leonard, Jeffrey
Larson, Paul
Bankiewicz, Krystof S.
Article History
Received: 7 September 2020
Accepted: 3 June 2021
First Online: 12 July 2021
Competing interests
: N.G. reports relationships with Oscine Therapeutics (consulting) and Y-mAbs Therapeutics (consulting). K.H. reports that he is employed by Medical Neurogenetics Laboratories, a company that provides commercial diagnostic testing for aromatic <scp>l</scp>-amino acid decarboxylase deficiency. P.L. reports relationships with Axovant (Advisory Board), Neurocrine Biosciences (research funding, consulting), UniQure (research funding), Voyager Therapeutics (research funding), and Clearpoint Neuro (consulting). K.S.B. is the founder and equity holder of Brain Neurotherapy Bio. The remaining authors have no competing interests to disclose.